Discovery and Development of the CRISPR-Cas Genome Editing Technology

Friday, February 12, 2016: 1:00 PM-2:30 PM
Marriott Balcony B (Marriott Wardman Park)
The recent discovery of a bacterial immunity process and its associated enzymes (CRISPR-Cas) has enabled a powerful, yet remarkably simple, genome editing technology that has quickly been put to use worldwide. Scientists are now able to program the CRISPR-Cas to selectively delete or alter almost any site within a complicated genome. The CRISPR-Cas-based genome editing technology has transformed the method of genetic material manipulation and will have profound impacts on our society. As interest in broadening CRISPR-Cas applications grows in areas of gene therapy, sustainable food supply, and even human enhancement, increased understanding of the fundamentals of the CRISPR-Cas biology and biochemistry is needed. Leaders of CRISPR-Cas research present the most recent findings on the mechanism of CRISPR-Cas enzymes and efforts to improve the specificity, and thereby the safety, of the technology.
Organizer:
Hong Li, Florida State University
Speakers:
Emmanuelle Charpentier, Max Planck Institute for Infection Biology
The Transformative CRISPR-Cas9 Genome Editing Tool: Lessons Learned from Bacteria
See more of: Biology and Neuroscience
See more of: Symposia